Ratings Aier Eye Hospital Group Co., Ltd.

Equities

300015

CNE100000GR6

Healthcare Facilities & Services

End-of-day quote Shenzhen S.E. Other stock markets 2024-12-10			5-day change	1st Jan Change
14.90 ^CNY	+1.92%		+1.36%	-5.82%

10-30	Aier Eye Hospital Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
10-25	Tranche Update on Aier Eye Hospital Group Co., Ltd.'s Equity Buyback Plan announced on October 26, 2023.	CI

Summary: Aier Eye Hospital Group Co., Ltd.

From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Highlights: Aier Eye Hospital Group Co., Ltd.

Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
The group's high margin levels account for strong profits.
Thanks to a sound financial situation, the firm has significant leeway for investment.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Over the past four months, analysts' average price target has been revised upwards significantly.

Weaknesses: Aier Eye Hospital Group Co., Ltd.

The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 36.11 times its estimated earnings per share for the ongoing year.
The company's "enterprise value to sales" ratio is among the highest in the world.
The company appears highly valued given the size of its balance sheet.
The company is highly valued given the cash flows generated by its activity.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
The group usually releases earnings worse than estimated.

Ratings Chart: Aier Eye Hospital Group Co., Ltd.

Source: Surperformance

ESG chart: Aier Eye Hospital Group Co., Ltd.

Source: Refinitiv

Sector Comparison:

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Composite Valuation	Capi. ($)
AIER EYE HOSPITAL GROUP CO., LTD.		19.1B
IHH HEALTHCARE		14.81B
APOLLO HOSPITALS ENTERPRISE LIMITED		12.3B
BANGKOK DUSIT MEDICAL SERVICES		11.87B
ENCOMPASS HEALTH CORPORATION		10.2B
THE ENSIGN GROUP, INC.	-	8.15B
FORTIS HEALTHCARE LIMITED		6.35B
RAMSAY HEALTH CARE LIMITED		5.67B
MOUWASAT MEDICAL SERVICES COMPANY		4.98B
Average		10.38B
Weighted average by Cap.

See all sector ratings

Investor Rating

Trading Rating

ESG Refinitiv

B+

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes